Long-term use of oral anticoagulants and the risk of fracture - PubMed (original) (raw)
Long-term use of oral anticoagulants and the risk of fracture
P J Caraballo et al. Arch Intern Med. 1999 Aug.
Abstract
Background: Vitamin K participates in bone metabolism and, since oral anticoagulants antagonize vitamin K, their use may increase the risk of osteoporosis.
Objective: To evaluate fracture risk at all skeletal sites following exposure to oral anticoagulants.
Methods: In a population-based retrospective cohort study, 572 Olmsted County, Minnesota, women 35 years or older at their first lifetime venous thromboembolism event between 1966 and 1990 were followed up for fractures. Risk was assessed by comparing new fractures with the number expected from sex- and age-specific fracture incidence rates for the general population (standardized incidence ratio [SIR]).
Results: Altogether, 480 fractures occurred during 6314 person-years of follow-up. Increasing exposure to oral anticoagulation was associated with an increased SIR for vertebral fractures: at less than 3 months of exposure, 2.4 (95% confidence interval [CI], 1.6-3.4); 3 to less than 12 months, 3.6 (95% CI, 2.5-4.9); and 12 months or more, 5.3 (95% CI, 3.4-8.0); and for rib fractures: at less than 3 months, 1.6 (95% CI, 0.9-2.7); 3 to less than 12 months, 1.6 (95% CI, 0.9-2.6); and 12 months or more, 3.4 (95% CI, 1.8-5.7). The data revealed no increased risk for other types of fractures. Oral anticoagulation for 12 months or more was an independent predictor of vertebral fractures (P = .009) and rib fractures (P = .02), but not other fractures.
Conclusions: Long-term exposure to oral anticoagulation is associated with an increased risk of vertebral and rib fractures. The mechanism by which this occurs is still unclear and needs further investigation.
Similar articles
- Long-term fracture risk among infertile women: a population-based cohort study.
Melton LJ 3rd, Hesdorffer DC, Malkasian GD, Atkinson EJ, Brinton LA, O'Fallon WM. Melton LJ 3rd, et al. J Womens Health Gend Based Med. 2001 Apr;10(3):289-97. doi: 10.1089/152460901300140040. J Womens Health Gend Based Med. 2001. PMID: 11389789 - Long-term fracture risk following renal transplantation: a population-based study.
Vautour LM, Melton LJ 3rd, Clarke BL, Achenbach SJ, Oberg AL, McCarthy JT. Vautour LM, et al. Osteoporos Int. 2004 Feb;15(2):160-7. doi: 10.1007/s00198-003-1532-y. Epub 2003 Dec 9. Osteoporos Int. 2004. PMID: 14666400 - Vitamin K antagonists' use and fracture risk: results from a systematic review and meta-analysis.
Veronese N, Bano G, Bertozzo G, Granziera S, Solmi M, Manzato E, Sergi G, Cohen AT, Correll CU. Veronese N, et al. J Thromb Haemost. 2015 Sep;13(9):1665-75. doi: 10.1111/jth.13052. Epub 2015 Aug 10. J Thromb Haemost. 2015. PMID: 26179400 Review. - Primary hyperparathyroidism and the risk of fracture: a population-based study.
Khosla S, Melton LJ 3rd, Wermers RA, Crowson CS, O'Fallon Wm, Riggs Bl. Khosla S, et al. J Bone Miner Res. 1999 Oct;14(10):1700-7. doi: 10.1359/jbmr.1999.14.10.1700. J Bone Miner Res. 1999. PMID: 10491217 - Warfarin use and fracture risk.
Booth SL, Mayer J. Booth SL, et al. Nutr Rev. 2000 Jan;58(1):20-2. doi: 10.1111/j.1753-4887.2000.tb01820.x. Nutr Rev. 2000. PMID: 10697390 Review.
Cited by
- Nano optical and electrochemical sensors and biosensors for detection of narrow therapeutic index drugs.
Shayesteh OH, Mahjub R, Ranjbar A, Derakhshandeh K, Jamshidi M. Shayesteh OH, et al. Mikrochim Acta. 2021 Nov 6;188(12):411. doi: 10.1007/s00604-021-05003-9. Mikrochim Acta. 2021. PMID: 34741213 Review. - Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women.
Knapen MH, Schurgers LJ, Vermeer C. Knapen MH, et al. Osteoporos Int. 2007 Jul;18(7):963-72. doi: 10.1007/s00198-007-0337-9. Epub 2007 Feb 8. Osteoporos Int. 2007. PMID: 17287908 Free PMC article. Clinical Trial. - A prospective cohort study of renal function and bone turnover in adults with hepatitis B virus (HBV)-HIV co-infection with high prevalence of tenofovir-based antiretroviral therapy use.
Gizaw A, King WC, Hinerman AS, Chung RT, Lisker-Melman M, Ghany MG, Khalili M, Jain MK, Graham J, Swift-Scanlan T, Kleiner DE, Sulkowski M, Wong DK, Sterling RK; HIV-HBV Cohort Study of the Hepatitis B Research Network. Gizaw A, et al. HIV Med. 2023 Jan;24(1):55-74. doi: 10.1111/hiv.13322. Epub 2022 May 16. HIV Med. 2023. PMID: 35578388 Free PMC article. - Role of the Microbiome in Regulating Bone Metabolism and Susceptibility to Osteoporosis.
Cronin O, Lanham-New SA, Corfe BM, Gregson CL, Darling AL, Ahmadi KR, Gibson PS, Tobias JH, Ward KA, Traka MH, Rossi M, Williams C, Harvey NC, Cooper C, Whelan K, Uitterlinden AG, O'Toole PW, Ohlsson C, Compston JE, Ralston SH. Cronin O, et al. Calcif Tissue Int. 2022 Mar;110(3):273-284. doi: 10.1007/s00223-021-00924-2. Epub 2021 Dec 6. Calcif Tissue Int. 2022. PMID: 34870723 Free PMC article. - Vitamin K and Bone Health: A Review on the Effects of Vitamin K Deficiency and Supplementation and the Effect of Non-Vitamin K Antagonist Oral Anticoagulants on Different Bone Parameters.
Rodríguez-Olleros Rodríguez C, Díaz Curiel M. Rodríguez-Olleros Rodríguez C, et al. J Osteoporos. 2019 Dec 31;2019:2069176. doi: 10.1155/2019/2069176. eCollection 2019. J Osteoporos. 2019. PMID: 31976057 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical